BENEFITS OF DAXXIFY
- See results fast - DAXXIFY ® kicks in quickly. You may see results as early as the next day after treatment, and typically within 2 days.
- Watch results last - DAXXIFY ® is long lasting and keeps frown lines smoother with the convenience of as few as 2 treatments a year.
- The DAXXIFY ® Look - A better look to skin texture after treatment. Smooths even the deepest lines.
DAXXIFY - AN INNOVATIVE FORMULTATION
DAXXIFY ® is the first innovation in injectable frown line treatments in 20 years.
Until now, there never was an injectable wrinkle treatment formulated with a peptide.
Our peptide helps stabilize the active ingredient, instead of using human blood products like conventional frown line treatments. It also has no animal byproducts.
The peptide also enhances attachment of the active ingredient, acting like a magnet and making more toxin available to enter nerve cells.
DAXXIFY FAQ's
DAXXIFY ® is FDA approved to smooth moderate to severe lines between the brows. It is the only frown line treatment powered by a peptide.
The active ingredient in DAXXIFY ® is a purified protein called botulinum toxin type A.
DAXXIFY ® could be for you if you would like to improve the look of your frown lines with a product that's fast acting, long lasting and delivers a better look.*
All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, Botox ® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport ®, another frown line treatment, uses HSA as a stabilizer and cow's milk protein as a protectant.
DAXXIFY ® is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.
DAXXIFY ® is unique because it’s the only frown line treatment formulated with a peptide. The peptide helps eliminate the need for human or animal products to stabilize the active ingredient, botulinum toxin A. The peptide also enhances attachment of the active ingredient, acting like a magnet and making more toxin available to enter nerve cells. The peptide formulation delivers outstanding results that are fast, last, and give a better look to the skin’s texture after treatment.*
In short, no, and here’s why. Units are like fingerprints—they are a proprietary measurement of a treatment’s unique potency.
Because of the differences in how treatments are formulated and tested, you cannot compare or convert Units between them, just like you cannot compare 2 fingerprints.
A clearer way to understand dosing is to look at how many nanograms of active ingredient (botulinum toxin type A) a product has.
Double the Units does not mean double the dose.
DAXXIFY ®
Approved frown line dose: 40 Units Amount of active ingredient: 0.18 nanograms
Botox ® Cosmetic
Approved frown line dose: 20 Units Amount of active ingredient: 0.18 nanograms
DAXXIFY ® is manufactured in California, and the only prescription frown line treatment made in the United States. Conventional frown line treatments are manufactured in other countries, then imported into the United States.
In 2002, physicians and entrepreneurs founded a start-up in Silicon Valley, California to explore the use of peptides in biologics for different therapeutic uses. Their goal was to utilize peptides to transport biologics, typically large molecules, through the skin.
The initial idea was to formulate botulinum toxin type A, the active ingredient in DAXXIFY ® , with a peptide to see if it could be applied topically to the skin to treat crow’s feet wrinkles. Through this process, scientists discovered that the formulation was optimally administered through injection. Several clinical studies were created to determine the correct dose for an injectable product that would treat frown lines.
DAXXIFY ® was studied in the largest-ever clinical study for a frown line treatment and included more than 2,800 people across different ages and skin types. Here are some things you should know about DAXXIFY ® :
- There were no serious treatment-related side effects
- The active ingredient in DAXXIFY ® is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years
The safety and efficacy of DAXXIFY ® is well established, with more than 20 years of research. In fact, DAXXIFY ® has been studied in the largest-ever phase 3 clinical trial conducted for a frown line treatment and included more than 2,800 people across different ages and with different skin types. DAXXIFY ® was studied in patients with varying skin types.
No, not necessarily. The most common side effects observed in clinical trials occurred within one to two weeks after injection and lasted only a short while. This is consistent with other frown line treatments.
DAXXIFY ® is well studied, with no serious treatment-related side effects seen in large-scale clinical trials.
DAXXIFY ® minimizes the appearance of moderate to severe frown lines by temporarily relaxing the underlying muscles that cause these wrinkles. DAXXIFY ® is a long-lasting botulinum type A treatment with a novel peptide.
Facial fillers, also known as dermal fillers, are typically made of hyaluronic acid and are used to add volume, fullness, and structure to areas of the face. They can help contour cheekbones, soften lines around the nose and mouth, and volumize lips. Dermal fillers target volume loss rather than muscle-related wrinkles.
